SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Atif Akdas, MD
Marmara University Hospital
Study Chair - Bryan J. Donnelly, MD, FRCSC, MSC
Tom Baker Cancer Centre - Calgary
Study Chair - George Wilding, MD
University of Wisconsin, Madison
Study Chair - Maha Hadi A. Hussain, MD
University of Michigan Rogel Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- University of British Columbia
Vancouver, British Columbia, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Hopital Notre-Dame Du Chum
Montreal, Quebec, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Chus-Hopital Fleurimont
Sherbrooke, Quebec, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 1995
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 17 Apr 2017
- Registered enrollment
- 3,040
- Registry id
- NCT00002651
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.